Skip to content

Nonneoplastic Epithelial Disorders of Vulva and High Intensity Focused Ultrasound

Treatment of Nonneoplastic Epithelial Disorders of Skin and Mucosa of Vulva With High Intensity Focused Ultrasound

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02890277
Enrollment
120
Registered
2016-09-07
Start date
2016-01-31
Completion date
2017-12-31
Last updated
2017-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vulva Intraepithelial Nonneoplastic

Brief summary

Nonneoplastic epithelial disorders of skin and mucosa of vulva refer to a group of chronic diseases shown as female genital skin and mucosal tissue degeneration and pigmentation change. The main symptoms are vulval itching, squamous cell hyperplasia, vulval and perianal skin atrophy or thinning, hypopigmentation. The current treatments are primarily local drug or surgical treatments. However, the effect is not good enough, but the diseases often recur and severely affect patients' quality of life. In this study, the investigators combined the technology of high intensity focused ultrasound (HIFU) (ultrasound device made by Mianyang Sonic electronic LLC, Mianyang China, registration number: 2005-2230099} with special drug to treat. The data from colposcopy and biopsy pathology were collected before and after treatment to create the objective identifying degree of the disease by with grading methods and evaluate the treatment effect. At the meantime, the standardized treatment procedure, methods and efficacy criterion were all stipulated to achieve satisfactory results, which could be used to clinical treatments. So far, the investigators have not seen similar study reported internationally.

Interventions

DEVICEthe high intensity focused ultrasound (Mianyang Sonic electronic LLC)
DRUGFu Tiankang disposable vaginal filling suppository, Albothyl (Policresulen Solution) , and the gynecologic medical antimicrobial dressing gel (chitosan gel).

Sponsors

Jinan Military General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 78 Years
Healthy volunteers
No

Inclusion criteria

* patients with clinically and biopsy confirmed non-neoplastic lesions of genital skin and mucous membrane (non-neoplasia epithelial disorders of skin and mucosa of vulva). Symptoms include repeated itching, discoloration, rhagades, loss of skin elasticity and dyspareunia that affect the patients' quality of life.

Exclusion criteria

* atypical hyperplasia or vulvar cancer confirmed by biopsy of genital lesions; * vulvovaginal or other gynecological trauma, acute inflammatory diseases and other acute illness in need of urgent care; * combined with other serious gynecological diseases (symptomatic hysteromyoma, ovarian tumor, etc.), and/or severe organ diseases (such as heart, lung, brain and renal disease/failure) that need immediate treatment; * other type of cancers that require urgent care.

Design outcomes

Primary

MeasureTime frameDescription
Grading changes of nonneoplastic epithelial disorders from colposcopy and biopsy pathologyOne month before treatment and 2,4,6 weeks and 2,6,12,24 monthes after treatmentThe data from colposcopy and biopsy pathology were collected before and after treatment to create the objective identifying degree of the disease by with grading methods and evaluate the treatment effect.

Countries

China

Contacts

Primary ContactGeping Yin, M.D.
ygpwylll@hotmail.com86-0531-51666230

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026